Skip to main content

Table 1 Side effects of ruxolitinib

From: Ruxolitinib found to cause eyelash growth: a case report

 

Side effects

Treatment

Hematologic (dose-related)

Anemia, neutropenia, thrombocytopenia

CBC every 2–4 weeks

Reduce dose

Blood transfusion for anemia

Dermatologic

Bruising

 

Non-melanoma skin cancer (basal, squamous, Merkel)

Periodic skin examination

Neurologic

Progressive multifocal encephalopathy

Discontinue ruxolitinib

Headache

 

Dizziness

 

Endocrine

Hypercholesterolemia, elevated low-density lipoprotein, elevated triglycerides

Assess lipid panel 8–12 weeks after initiation

Gastrointestinal

Diarrhea

 

Limbal

Edema (arm, leg, hand, feet)

 

Immunologic

Tuberculosis

Manage tuberculosis

Herpes zoster

Manage zoster

Hepatitis B

Treat hepatitis

  1. CBC complete blood count